乳腺癌辅助内分泌治疗不良反应的循证管理方法
综述总结辅助内分泌治疗相关潮热、性功能障碍、体重增加、肌肉骨骼症状和疲劳的干预措施。涵盖激素与非激素药物、非药物方法及补充替代医学,提供循证管理策略以改善治疗依从性和生活质量。
要点
- 辅助内分泌治疗可致潮热、性功能障碍、体重增加、肌肉骨骼症状和疲劳。
- 绝经前患者因雌激素骤降,不良反应可能更突出。
- 管理策略包括药物、非药物及补充替代医学,需循证选择。
核心结论
- 综述汇总了辅助内分泌治疗相关不良反应的干预措施,提供最新循证管理方法。
研究设计与样本
- 综述综合评估激素与非激素药物、非药物方法及补充替代医学的疗效与安全性数据。
主要发现
- 辅助内分泌治疗相关不良反应包括潮热、性功能障碍、体重增加、肌肉骨骼症状和疲劳。
- 绝经前乳腺癌幸存者因雌激素骤降,不良反应可能更突出。
- 管理不良反应有助于恢复癌症前的生活质量和情感社会功能。
临床怎么用
- 临床应基于循证证据选择干预措施管理辅助内分泌治疗相关不良反应,以提高依从性和生活质量。
- 对绝经前患者需特别关注因雌激素骤降导致的不良反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The growing availability of more effective therapies has contributed to an increased survival of patients with breast cancer. In hormone receptor-positive early disease, increased survival is strongly correlated with the use of adjuvant endocrine therapy, but this therapy can cause side-effects that have major consequences in terms of treatment adherence and patients' quality of life. In premenopausal breast cancer survivors, these side-effects might be even more prominent due to the abrupt suppression of oestrogen associated with the most intense endocrine therapies. An important ambition of cancer care in the 21st century is to recover pre-cancer quality of life and emotional and social functions, which is only possible through the mitigation of the side-effects of anticancer treatments. This Review presents a comprehensive summary of the efficacy and safety data of the available interventions (hormonal and non-hormonal pharmacological strategies, non-pharmacological approaches, and complementary and alternative medicine) to control selected side-effects associated with adjuvant endocrine therapy (hot flashes, sexual dysfunction, weight gain, musculoskeletal symptoms, and fatigue), providing updated, evidence-based approaches for their management.
引用
- Franzoi MA, Agostinetto E, Perachino M, et al. Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. Lancet Oncol. 2021. PMID: 33891888. doi:10.1016/S1470-2045(20)30666-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。